KRT19 and neoplasm: Fang et al. reported that the combination of the peptide hormone prolactin (PRL) with the tumor markers Carcinoembryonic antigen (CEA) and cytokeratin 19 fragment (CYFRA21) increased the diagnostic efficacy of identifying non-small cell lung cancer (NSCLC) [35].